We have highlighted throughout this thesis that fragment-based drug design (FBDD) and structure-based drug design (SBDD) still constitute a number of challenges such as the risk associated with de novo SBDD and are time-consuming as they involve synthesis and validation of the binding mode of each derivative in the fragment/hit-optimization cycle. To overcome these hurdles, we combined FBDD or de novo SBDD projects with dynamic combinatorial chemistry (DCC) or protein-templated click chemistry (PTCC) to render the identification/optimization of hits/leads more efficient, using the aspartic protease endothiapepsin as a model system.The main achievements described in this thesis are: 1) the development of a powerful technique that combines de...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...
There is an urgent need for the development of efficient methodologies that accelerate drug discover...
Every medicine has had a long process from the beginning to the eventual active molecule. However, w...
We have highlighted throughout this thesis that fragment-based drug design (FBDD) and structure-base...
There is an urgent need for the development of efficient methodologies that accelerate drug discover...
Fragment-based drug design (FBDD) affords active compounds for biological targets. While there are n...
Fragment-based drug design (FBDD) has emerged as an efficient hit-identification and/or-optimization...
Fragment-based drug design (FBDD) affords active compounds for biological targets. While there are n...
Dynamic combinatorial chemistry (DCC) has emerged as a powerful strategy to identify ligands for bio...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...
There is an urgent need for the development of efficient methodologies that accelerate drug discover...
Every medicine has had a long process from the beginning to the eventual active molecule. However, w...
We have highlighted throughout this thesis that fragment-based drug design (FBDD) and structure-base...
There is an urgent need for the development of efficient methodologies that accelerate drug discover...
Fragment-based drug design (FBDD) affords active compounds for biological targets. While there are n...
Fragment-based drug design (FBDD) has emerged as an efficient hit-identification and/or-optimization...
Fragment-based drug design (FBDD) affords active compounds for biological targets. While there are n...
Dynamic combinatorial chemistry (DCC) has emerged as a powerful strategy to identify ligands for bio...
Structure-based design (SBD) can be used for the design and/or optimization of new inhibitors for a ...
There is an urgent need for the development of efficient methodologies that accelerate drug discover...
Every medicine has had a long process from the beginning to the eventual active molecule. However, w...